Literature DB >> 10985912

An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria.

J W Radomski1, S M Dursun, M A Reveley, S P Kutcher.   

Abstract

Serotonin-related adverse side-effects of psychotropic drugs were first recorded in humans in 1960. However, since 1991, these related cases have been diagnosed as 'serotonin syndrome (SS)' according to the criteria reported by Sternbach. In this article, we have reviewed and further explored the validity of these criteria. The clinical profile of 24 cases of the SS published between 1991 and 1995 has been analysed in detail and compared with the symptomatology of 38 previous cases which were also further analysed. Mainly Medline and references from other reports were used to review these cases. The general concept put forward by Sternbach has been approved. On the basis of the severity of overall clinical presentation, it appeared that there is a need to further classify SS into three main groups as: (1) mild state of serotonin-related symptoms; (2) serotonin syndrome (full-blown form); (3) toxic states. Furthermore, the detailed analysis of the SS cases published so far suggests that 'the diagnostic criteria for SS' also require further revision, and these are presented here. We also review, present and discuss the guidelines for the management and treatment of SS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985912     DOI: 10.1054/mehy.2000.1047

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  32 in total

Review 1.  Serotonin syndrome: a brief review.

Authors:  Philippe Birmes; Dominique Coppin; Laurent Schmitt; Dominique Lauque
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

Review 2.  Serotonin toxicity: a short review of the literature and two case reports involving citalopram.

Authors:  G Talarico; G Tosto; S Pietracupa; E Piacentini; M Canevelli; G L Lenzi; G Bruno
Journal:  Neurol Sci       Date:  2011-04-14       Impact factor: 3.307

3.  Recognition and treatment of serotonin syndrome.

Authors:  Christopher Frank
Journal:  Can Fam Physician       Date:  2008-07       Impact factor: 3.275

4.  Use of a Bioinformatics-Based Toxicity Scoring System to Assess Serotonin Burden and Predict Population-Level Adverse Drug Events from Concomitant Serotonergic Drug Therapy.

Authors:  Vaughn L Culbertson; Shaikh Emdadur Rahman; Grayson C Bosen; Matthew L Caylor; Dong Xu
Journal:  Pharmacotherapy       Date:  2019-02       Impact factor: 4.705

Review 5.  Depression in Parkinson's disease.

Authors:  Theresa A Zesiewicz; Robert A Hauser
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

6.  Serotonin syndrome presenting as febrile encephalopathy with CSF pleocytosis: a report of three cases.

Authors:  Sanjay Prakash; Prayag Makwana; Chaturbhuj Rathore; Ankit Dave
Journal:  Neurol Sci       Date:  2016-06-20       Impact factor: 3.307

Review 7.  [Serotonin syndrome and pain medication : What is relevant for practice?].

Authors:  M Schenk; S Wirz
Journal:  Schmerz       Date:  2015-04       Impact factor: 1.107

Review 8.  Drug Interaction and Serotonin Toxicity with Opioid Use: Another Reason to Avoid Opioids in Headache and Migraine Treatment.

Authors:  Hossein Ansari; Leila Kouti
Journal:  Curr Pain Headache Rep       Date:  2016-08

9.  The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports.

Authors:  Randolph W Evans
Journal:  MedGenMed       Date:  2007-09-05

10.  Methylene blue-associated serotonin syndrome: a 'green' encephalopathy after parathyroidectomy.

Authors:  Michael Rowley; Kevin Riutort; David Shapiro; John Casler; Emir Festic; William D Freeman
Journal:  Neurocrit Care       Date:  2009-03-05       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.